Healthcare & Life Sciences
Palisade Bio
Palisade Bio is a Healthcare & Life Sciences startup, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Palisade Bio
Palisade Bio is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Palisade Bio is a late-stage biopharmaceutical company developing oral therapies to treat acute and chronic gastrointestinal complications caused by post-operative digestive enzyme damage.
Explore Palisade Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.